Empire Financial Management Company »

AstraZeneca shares owned by Empire Financial Management Company

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Empire Financial Management Company from 13F filings

Historical chart of Empire Financial Management Company investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Empire Financial Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Empire Financial Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $808k 12k 67.35
2023-09-30 $813k 12k 67.72
2023-06-30 $859k 12k 71.57
2023-03-31 $833k 12k 69.41

More positions owned by Empire Financial Management Company

Etf Series Solutions Distillate Us (DSTL)
Microsoft Corporation (MSFT)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Litman Gregory Funds Trust Imgp Dbi Managed (DBMF)
Alphabet Cap Stk Cl A (GOOGL)
International Business Machines (IBM)
Pacer Fds Tr Globl Cash Etf (GCOW)
Abbott Laboratories (ABT)
Etf Series Solutions Distillate Intnl (DSTX)
John Hancock Exchange Traded Multifactr Sml (JHSC)
Procter & Gamble Company (PG)
Home Depot (HD)
Ea Ser Tr Marketdesk Focus (FDIV)

View all positions for Empire Financial Management Company

Top funds holding AstraZeneca

T. Rowe Price Associates
Wellington Management Company
PRIMECAP Management Company
FMR
Jennison Associates
Franklin Resources
Morgan Stanley
Sanders Capital
Goldman Sachs Group
Fisher Investments
Atlantic Trust
BlackRock
Bank of America Corporation
Holocene Advisors
Neuberger Berman Group

View all funds holding AstraZeneca